- Home
- PLBC vs NLSP Comparison
PLBC vs NLSP Comparison
Compare PLBC & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBC
- NLSP
- Stock Information
- Founded
- PLBC 1980
- NLSP 2015
- Country
- PLBC United States
- NLSP Switzerland
- Employees
- PLBC N/A
- NLSP N/A
- Industry
- PLBC Finance Companies
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- PLBC Finance
- NLSP Health Care
- Exchange
- PLBC Nasdaq
- NLSP Nasdaq
- Market Cap
- PLBC 224.2M
- NLSP 243.8M
- IPO Year
- PLBC 2005
- NLSP 2021
- Fundamental
- Price
- PLBC $38.82
- NLSP $5.10
- Analyst Decision
- PLBC Buy
- NLSP
- Analyst Count
- PLBC 1
- NLSP 0
- Target Price
- PLBC $45.00
- NLSP N/A
- AVG Volume (30 Days)
- PLBC 14.7K
- NLSP 27.8K
- Earning Date
- PLBC 10-16-2024
- NLSP 10-18-2024
- Dividend Yield
- PLBC 2.84%
- NLSP N/A
- EPS Growth
- PLBC N/A
- NLSP N/A
- EPS
- PLBC 4.80
- NLSP N/A
- Revenue
- PLBC $78,618,000.00
- NLSP N/A
- Revenue This Year
- PLBC N/A
- NLSP N/A
- Revenue Next Year
- PLBC $33.17
- NLSP N/A
- P/E Ratio
- PLBC $7.92
- NLSP N/A
- Revenue Growth
- PLBC 5.13
- NLSP N/A
- 52 Week Low
- PLBC $32.50
- NLSP $4.08
- 52 Week High
- PLBC $45.00
- NLSP $40.60
- Technical
- Relative Strength Index (RSI)
- PLBC 44.81
- NLSP 42.53
- Support Level
- PLBC $38.40
- NLSP $4.72
- Resistance Level
- PLBC $39.82
- NLSP $5.36
- Average True Range (ATR)
- PLBC 1.48
- NLSP 0.63
- MACD
- PLBC -0.38
- NLSP 0.05
- Stochastic Oscillator
- PLBC 20.55
- NLSP 35.28
About PLBC Plumas Bancorp
Plumas Bancorp is a bank holding company that provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.